NASDAQ:AMPH
Amphastar Pharmaceuticals Stock News
$43.48
+0.740 (+1.73%)
At Close: May 17, 2024
Amphastar Pharmaceuticals, Inc. (AMPH) on Q2 2021 Results - Earnings Call Transcript
11:52pm, Monday, 09'th Aug 2021
Amphastar Pharmaceuticals, Inc. (AMPH) on Q2 2021 Results - Earnings Call Transcript
Amphastar Pharmaceuticals (AMPH) Meets Q2 Earnings Estimates
07:59pm, Monday, 09'th Aug 2021
Amphastar (AMPH) delivered earnings and revenue surprises of 0.00% and 0.28%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2021
04:05pm, Monday, 09'th Aug 2021
Reports Net Revenues of $101.7 Million for the Three Months Ended June 30, 2021 RANCHO CUCAMONGA, CA / ACCESSWIRE / August 9, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "
Amphastar Pharmaceuticals (AMPH) to Report Q2 Results: Wall Street Expects Earnings Growth
04:44pm, Thursday, 29'th Jul 2021
Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9th, 2021
04:20pm, Thursday, 29'th Jul 2021
RANCHO CUCAMONGA, CA / ACCESSWIRE / July 29, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2021 ended June 30, 2021, af
Amphastar Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference
04:05pm, Tuesday, 15'th Jun 2021
RANCHO CUCAMONGA, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Comm
Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
06:00am, Thursday, 27'th May 2021
RANCHO CUCAMONGA, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Commu
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q1 2021 Results - Earnings Call Transcript
04:48am, Sunday, 09'th May 2021
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q1 2021 Results - Earnings Call Transcript
Amphastar Announces Buyback of 26% of the Equity in its ANP Subsidiary and Spin-off its Hanxin Subsidiary
04:05pm, Friday, 07'th May 2021
RANCHO CUCAMONGA, Calif., May 07, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced the restructuring of its Chinese subsidiaries, primarily Amphastar Nanjing Pharmaceu
Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Top Estimates
07:32pm, Thursday, 06'th May 2021
Amphastar (AMPH) delivered earnings and revenue surprises of 42.11% and 6.08%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Amphastar Pharmaceuticals Q1 Earnings
05:45pm, Thursday, 06'th May 2021
Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 58.82% over the past year to $0.27, w
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2021
04:05pm, Thursday, 06'th May 2021
Reports Net Revenues of $103.0 Million for the Three Months Ended March 31, 2021
Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection
06:00am, Monday, 03'rd May 2021
RANCHO CUCAMONGA, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company's Abbr
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 6th, 2021
06:00am, Thursday, 29'th Apr 2021
RANCHO CUCAMONGA, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its first quarter of 2021 ended March 31
3 Generic Drug Stocks to Watch Amid COVID-Related Recovery
09:09am, Wednesday, 14'th Apr 2021
3 Generic Drug Stocks to Watch Amid COVID-Related Recovery
